MBX Biosciences, Inc. (MBX)
52.46
-2.08
(-3.81%)
USD |
NASDAQ |
Oct 08, 15:05
MBX Biosciences Market Cap : 2.515B for Oct. 8, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 07, 2026 | 2.615B |
| October 06, 2026 | 2.729B |
| October 05, 2026 | 2.807B |
| October 02, 2026 | 2.806B |
| October 01, 2026 | 2.712B |
| September 30, 2026 | 2.811B |
| September 29, 2026 | 2.769B |
| September 28, 2026 | 2.759B |
| September 25, 2026 | 2.572B |
| September 24, 2026 | 2.656B |
| September 23, 2026 | 2.776B |
| September 22, 2026 | 2.972B |
| September 21, 2026 | 2.922B |
| September 18, 2026 | 3.017B |
| September 17, 2026 | 3.064B |
| September 16, 2026 | 2.952B |
| September 15, 2026 | 2.929B |
| September 14, 2026 | 2.853B |
| September 11, 2026 | 2.830B |
| September 10, 2026 | 2.922B |
| September 09, 2026 | 3.017B |
| September 08, 2026 | 3.020B |
| September 04, 2026 | 2.959B |
| September 03, 2026 | 2.945B |
| September 02, 2026 | 2.920B |
| Date | Value |
|---|---|
| September 01, 2026 | 2.922B |
| August 31, 2026 | 2.954B |
| August 28, 2026 | 3.021B |
| August 27, 2026 | 3.183B |
| August 26, 2026 | 3.201B |
| August 25, 2026 | 3.290B |
| August 24, 2026 | 3.183B |
| August 21, 2026 | 3.181B |
| August 20, 2026 | 3.181B |
| August 19, 2026 | 3.280B |
| August 18, 2026 | 3.190B |
| August 17, 2026 | 3.273B |
| August 14, 2026 | 3.288B |
| August 13, 2026 | 3.216B |
| August 12, 2026 | 3.211B |
| August 11, 2026 | 3.165B |
| August 10, 2026 | 3.172B |
| August 07, 2026 | 3.252B |
| August 06, 2026 | 3.218B |
| August 05, 2026 | 3.236B |
| August 04, 2026 | 3.390B |
| August 03, 2026 | 3.064B |
| July 31, 2026 | 3.136B |
| July 30, 2026 | 3.162B |
| July 29, 2026 | 3.043B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amylyx Pharmaceuticals, Inc. | 3.047B |
| ANI Pharmaceuticals, Inc. | 1.657B |
| Corcept Therapeutics, Inc. | 12.76B |
| Veru, Inc. | 41.09M |
| Johnson & Johnson | 617.54B |
Market Cap Related Metrics
| PEG Ratio | -4.961 |
| Price to Book Value | 6.142 |
| Price | 52.46 |
| Earnings Yield | -4.59% |
| PEGY Ratio | -4.961 |